Rural Interventions for Screening Effectiveness (RISE)
September 27, 2023 updated by: Electra Paskett, Ohio State University Comprehensive Cancer Center
Comparative Effectiveness of Interventions to Improve Screening Among Rural Women
This randomized clinical trial studies how well a tailored interactive digital versatile disc (DVD) with or without patient navigation works in improving screening rates in rural women for breast cancer, cervical cancer or colorectal cancer.
A tailored interactive DVD and patient navigation may help rural women to learn more about cancer screening and to better understand the results.
Study Overview
Status
Completed
Detailed Description
PRIMARY OBJECTIVES:
I. Compare the effectiveness of a tailored and interactive DVD (TIDVD) versus (vs.) TIDVD + telephone-based patient navigation (PN) intervention (TIDVD + PN) vs. usual care (UC), to increase guideline-based cancer screening rates at 12 months post randomization for breast cancer (BC), cervical cancer (CC), and colorectal cancer (CRC) among 1058 women age 50 to 74 living in rural northwest Ohio and northeast Indiana.
II. Compare the cost effectiveness of the TIDVD and the TIDVD + PN intervention vs. UC, for adherence to each screening outcome or combination of screening tests.
OUTLINE: Patients are randomized to 1 of 3 arms.
Arm I: Patients watch a tailored interactive DVD program and answer questions posed by the DVD program.
Arm II: Patients engage in TIDVD and PN.
Arm III: Patients receive brochures that explain and provide encouragement for cancer screening.
After completion of the study, patients are followed up at 2 and 12 months.
Study Type
Interventional
Enrollment (Actual)
985
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, United States, 43210
- Ohio State University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 74 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Be non-adherent to one or more recommended screenings for BC, CC, or CRC by Medical Record Review (MRR)
- Reside in one of 32 rural counties in Indiana (IN) or Ohio (OH)
- Provide informed consent
- Able to speak/read English
- Have access to a DVD player or computer that can play DVDs
Exclusion Criteria:
- Have a personal or family history of any hereditary/genetic cancer syndrome such as BRCA1 and BRCA2 polymorphisms, hereditary nonpolyposis colon cancer, or familial adenomatous polyposis
- Have a personal history of inflammatory bowel disease (Crohn's disease or colitis), colon polyps, or a history of cancer except non-melanoma skin cancer
- Have a first degree relative with a history of breast or colorectal cancer
- Plan to move outside of the country within the next year
- Reside in a nursing home or other institution
- Are pregnant or intend to become pregnant during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm I (TIDVD)
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
|
Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
Other Names:
|
|
Experimental: Arm II (TIDVD, PN)
Educational Intervention-DVD & Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator.
|
Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
|
|
Experimental: Arm III (UC)
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
|
Educational Intervention via brochure: In this arm of the educational intervention the participant receives brochures
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms
Time Frame: Up to 12 months
|
Will be tested initially with pair-wise chi-square tests.
Binary logistic regression analysis will be used to compare the two interventions and the UC group on the binary dependent variable (adherence), while adjusting for any potentially confounding covariates.
The models will be controlled for any demographic covariate (e.g., age, education) for which the randomized groups differ significantly at baseline using a liberal significance level of 0.20 to achieve conservative adjustment.
As a sensitivity analysis, multiple imputation will be used to impute the adherence outcome for participants.
|
Up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost Effectiveness of Each Intervention
Time Frame: Up to 12 months
|
Cost-effectiveness analysis (CEA) implies a comparison of whether the cost per unit of outcome in one situation exceeds that in another.
Unless the outcome measures are comparable, this is not possible.
Will be able to examine outcomes of the interventions and the UC group (participants who up to date with all three cancer screening guidelines at 12 month follow-up).
CEA will consist of measuring the incremental cost of achieving the observed incremental outcomes, but not a cost-effectiveness ratio in standard terms.
|
Up to 12 months
|
|
Cost of the Interventions
Time Frame: Up to 12 months
|
In the model implemented in this study, the patient navigators spend full time in that activity.
Thus, the costs of implementation are straightforward and obtainable.
Even though the navigator is full-time, data were collected concerning broad categories of time use through a structured time log so that the cost of specific components (e.g., arranging transportation) can be estimated more accurately.
A developed Participant Encounter Form and a Tracking Log of Direct Participant Contacts were used to provide the majority of this information.
|
Up to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Electra Paskett, PhD, Ohio State University Comprehensive Cancer Center
- Principal Investigator: Victoria Champion, PhD, Indiana University School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2016
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
July 1, 2020
Study Registration Dates
First Submitted
June 6, 2016
First Submitted That Met QC Criteria
June 6, 2016
First Posted (Estimated)
June 9, 2016
Study Record Updates
Last Update Posted (Actual)
October 2, 2023
Last Update Submitted That Met QC Criteria
September 27, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OSU-16108
- NCI-2016-00774 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- R01CA196243 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
These data will only be used to characterize/compare the group individual to those who are eligible and agree to participate; with those who are ineligible and will not be shared after the completion of the study with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.